151 related articles for article (PubMed ID: 38715560)
21. Bilateral central retinal vein occlusion as an initial presentation of Waldenström macroglobulinemia: a case report.
Shrestha S; Poddar E; Bashyal B; Adhikari A; Pathak P; Acharya S; Sapkota S; Bhattarai A; Pant SR; Shrestha A
J Med Case Rep; 2023 Feb; 17(1):59. PubMed ID: 36804919
[TBL] [Abstract][Full Text] [Related]
22. Extensive multifocal and pleomorphic pulmonary lesions in Waldenström macroglobulinemia: A case report.
Zhao DF; Ning HY; Cen J; Liu Y; Qian LR; Han ZH; Shen JL
World J Clin Cases; 2020 Jun; 8(11):2305-2311. PubMed ID: 32548160
[TBL] [Abstract][Full Text] [Related]
23. Waldenstrom macroglobulinemia involving the superior rectus muscle.
Hellman JB; Harocopos GJ; Lin LK
Am J Ophthalmol Case Rep; 2018 Jun; 10():304-306. PubMed ID: 29780960
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.
Elba S; Castellino A; Soriasio R; Castellino C; Bonferroni M; Mattei D; Strola G; Drandi D; Mordini N; Foglietta M; Rapezzi D; Celeghini I; Grasso M; Giordano F; Fraternali Orcioni G; Massaia M
J Med Case Rep; 2020 Jun; 14(1):75. PubMed ID: 32564775
[TBL] [Abstract][Full Text] [Related]
25. Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline.
Reece D; Imrie K; Stevens A; Smith CA;
Curr Oncol; 2006 Oct; 13(5):160-72. PubMed ID: 22792013
[TBL] [Abstract][Full Text] [Related]
26. Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Chakraborty R; Kapoor P; Ansell SM; Gertz MA
Expert Rev Anticancer Ther; 2015; 15(10):1143-56. PubMed ID: 26196236
[TBL] [Abstract][Full Text] [Related]
27. Waldenström macroglobulinemia: my way.
Gertz M
Leuk Lymphoma; 2013 Mar; 54(3):464-71. PubMed ID: 22860921
[TBL] [Abstract][Full Text] [Related]
28. Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study.
Owen RG; McCarthy H; Rule S; D'Sa S; Thomas SK; Tournilhac O; Forconi F; Kersten MJ; Zinzani PL; Iyengar S; Kothari J; Minnema MC; Kastritis E; Aurran-Schleinitz T; Cheson BD; Walter H; Greenwald D; Chen DY; Frigault MM; Hamdy A; Izumi R; Patel P; Wei H; Lee SK; Mittag D; Furman RR
Lancet Haematol; 2020 Feb; 7(2):e112-e121. PubMed ID: 31866281
[TBL] [Abstract][Full Text] [Related]
29. Case report: Circulating tumor DNA technology displays temporal and spatial heterogeneity in Waldenström macroglobulinemia during treatment with
Zhu J; Zhu X; Xie F; Ding Y; Lu H; Dong Y; Li P; Fu J; Liang A; Zeng Y; Xiu B
Pathol Oncol Res; 2023; 29():1611070. PubMed ID: 37151353
[No Abstract] [Full Text] [Related]
30. Bing-Neel Syndrome: An Initial Manifestation of Waldenstrom Macroglobulinemia.
Lee MS; Sathe S; Valasapalli S; Grosse Perdekamp M
Cureus; 2021 Nov; 13(11):e19402. PubMed ID: 34926004
[TBL] [Abstract][Full Text] [Related]
31. An unusual case of cutaneous Waldenström macroglobulinemia with the MYD88 L265P mutation.
Minzenmayer AN; Miranda RN; Powell PR; Parekh PK
J Cutan Pathol; 2020 Sep; 47(9):850-853. PubMed ID: 32335928
[TBL] [Abstract][Full Text] [Related]
32.
Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
[No Abstract] [Full Text] [Related]
33. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
Nazlı ŞB; Sevindik M
Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous amyloidosis as the first presentation of Waldenstrom macroglobulinemia.
Rafiei R; Eftekhari H; Rafiee B
Caspian J Intern Med; 2020 May; 11(3):340-342. PubMed ID: 32874445
[TBL] [Abstract][Full Text] [Related]
35. Biclonal lymphoplasmacytic lymphoma/Waldenström macroglobulinemia associated with POEMS syndrome: A case report and literature review.
Wang Q; Liu Q; Liang H; Gao W
Oncol Lett; 2023 Mar; 25(3):97. PubMed ID: 36817054
[TBL] [Abstract][Full Text] [Related]
36. Waldenstrom's macroglobulinemia in the era of immunotherapy.
Vaxman I; Gertz M
Leuk Lymphoma; 2020 Jun; 61(6):1292-1304. PubMed ID: 31960730
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines.
Ansell SM; Kyle RA; Reeder CB; Fonseca R; Mikhael JR; Morice WG; Bergsagel PL; Buadi FK; Colgan JP; Dingli D; Dispenzieri A; Greipp PR; Habermann TM; Hayman SR; Inwards DJ; Johnston PB; Kumar SK; Lacy MQ; Lust JA; Markovic SN; Micallef IN; Nowakowski GS; Porrata LF; Roy V; Russell SJ; Short KE; Stewart AK; Thompson CA; Witzig TE; Zeldenrust SR; Dalton RJ; Rajkumar SV; Gertz MA
Mayo Clin Proc; 2010 Sep; 85(9):824-33. PubMed ID: 20702770
[TBL] [Abstract][Full Text] [Related]
38. A Rare Case of Waldenstrom Macroglobulinemia of the Rectosigmoid Colon.
Zelman S; Russell MB; Hojat A; Pilichowska M; Olans LB; Sterling MJ
ACG Case Rep J; 2021 Nov; 8(11):e00689. PubMed ID: 34849377
[TBL] [Abstract][Full Text] [Related]
39. Simple headache revealed a rare lymphoma: Waldenstrom macroglobulinemia with unique markers: a case report and review of the literature.
Awad AK; Elbadawy MA; Boury M; Rivera A; Motawea K; Shah J; Parnia S; Varney J
J Egypt Natl Canc Inst; 2022 Mar; 34(1):10. PubMed ID: 35253074
[TBL] [Abstract][Full Text] [Related]
40. Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia: A review.
Moore DC
J Oncol Pharm Pract; 2021 Dec; 27(8):1993-1999. PubMed ID: 34558376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]